Nicolas Charette

Prognostic value of adipose tissue and muscle mass in advanced colorectal cancer: a post hoc analysis of two non-randomized phase II trials

Nicolas Charette, Caroline Vandeputte, Lieveke Ameye et al. · BMC Cancer · 2019 · 102 citations · Full text

Kinetics of angiogenic changes in a new mouse model for hepatocellular carcinoma

Femke Heindryckx, Koen Mertens, Nicolas Charette et al. · Molecular Cancer · 2010 · 49 citations · Full text

Salirasib inhibits the growth of hepatocarcinoma cell lines in vitro and tumor growth in vivo through ras and mTOR inhibition

Nicolas Charette, Christine De Saeger, Valérie Lannoy et al. · Molecular Cancer · 2010 · 47 citations · Full text

Salirasib sensitizes hepatocarcinoma cells to TRAIL-induced apoptosis through DR5 and survivin-dependent mechanisms

Nicolas Charette, Christine De Saeger, Yves Horsmans et al. · Cell Death and Disease · 2013 · 38 citations · Full text

Oncology, Medicine, Apoptosis +14

Tumor reoxygenation following administration of Mitogen-Activated Protein Kinase inhibitors: A rationale for combination with radiation therapy

Oussama Karroum, Julie Kengen, Pierre Danhier et al. · Radiotherapy and Oncology · 2012 · 18 citations

Tumor Reoxygenation, Tumor Biology, Radiation Therapy +10